Covidence

What Covidence does

Covidence, operating through Veritas Health Innovation Ltd, is a Melbourne-headquartered non-profit SaaS enterprise founded in 2014 that provides a cloud-based workflow platform for systematic reviews and evidence synthesis. Its core product unifies citation import, title and abstract screening, full-text screening, data extraction, and risk of bias assessment into a single collaborative web application, supporting both individual researchers and large institutional programs. The platform integrates with reference managers (EndNote, Zotero, RefWorks, Mendeley) and standard formats (RIS, PubMed, CSV, PubMedXML), and exports to Cochrane's RevMan.

The technology layer combines classical review-management tooling with an emerging AI capability stack, including the Cochrane RCT Classifier for automated study-type filtering, AI Screening Automation for relevance-based sorting and PICO extraction, and AI-generated Data Extraction Suggestions (e.g., sponsorship source) with disclosed precision/recall benchmarks and a published decision matrix governing responsible release. The platform supports 100,000+ reviews, 2,500+ daily active users, and 750,000+ researchers across 200 countries.

Covidence generates revenue through two primary subscription streams: individual researcher plans at $339 (single review) and $907 (up to three reviews) per year, and quote-based multi-year institutional subscriptions for unlimited reviews and users. Free access is provided to researchers in low and middle-income countries and for COVID-19 research. Go-to-market is hybrid: product-led self-serve for individuals, combined with enterprise field sales and community-led adoption anchored by the 2015 Cochrane endorsement, plus partnerships with the Johanna Briggs Institute, Campbell Collaboration, and Guidelines International Network. The organization is structured as a registered charity with SEFA acting as its financial partner; no venture or equity funding is disclosed.

Name

Covidence

Legal name

Veritas Health Innovation Ltd

Website

https://covidence.org

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

51–100 employees

Short description

Covidence is a non-profit SaaS platform that streamlines systematic review workflows for academic researchers, universities, hospitals, and guideline-producing organizations, integrating AI-assisted screening and data extraction with reference manager interoperability.

Ownership category

akta.pro rank

Headquarters

HQ city

Melbourne

HQ country

Australia

HQ region

Oceania

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Individual Subscription Plans: Single plan at $339/year for one review with unlimited collaborators. Package plan at $907/year for up to 3 reviews. Annual billing model. Revenue from individual researchers and small teams.
2. Institutional/Organizational Licenses: Unlimited reviews and users organizational subscriptions for universities, hospitals, and societies. Quote-based pricing requiring sales consultation. Includes admin controls and visibility across reviews.
3. Non-profit Model Revenue: Covidence is a not-for-profit social enterprise. Revenue from subscriptions funds operations. Provides free access to users in low-income countries and those doing COVID-19 research.

Pricing tiers

Go-to-market motion4 records

Distribution channels4 records

Marketing channels10 records

Core offering

Covidence is a cloud-based SaaS platform that streamlines the production of systematic reviews by managing the entire evidence synthesis workflow, including citation import from reference managers (EndNote, Zotero, RefWorks, Mendeley), title/abstract screening, full text screening, data extraction, risk of bias assessment, and export. The platform embeds AI capabilities such as the Cochrane RCT Classifier and AI Screening Automation to accelerate screening and data extraction while maintaining methodological rigor. It is sold via individual subscriptions and organizational licenses to universities, hospitals, research societies, and government health agencies worldwide.

Product overview

Covidence is a cloud-based systematic review management platform built as a unified SaaS product for evidence synthesis. The core Covidence Platform provides end-to-end workflow support including citation import, screening, data extraction, risk of bias assessment, and export. The platform offers tiered access through Single and Package individual plans, and organizational subscriptions with unlimited reviews and users. AI capabilities are integrated as feature modules within the platform, including AI Screening Automation (relevance-based sorting, RCT tagging), AI Data Extraction Suggestions, and the Cochrane RCT Classifier. Additional services include Covidence Academy for training, a Research Insights Dashboard for institutional analytics, and a Knowledge Base for user support. The platform integrates with major reference managers (EndNote, Zotero, RefWorks, Mendeley) and supports standard formats (RIS, PubMed, CSV, PubMedXML).

Differentiator

Problem solved

Functional benefit

Products and services

• Covidence Platform Cloud-based systematic review management SaaS platform that streamlines evidence synthesis workflows including citation import from reference managers, title and abstract screening, full text screening, data extraction, risk of bias assessment, and export. Designed for academic researchers, universities, hospitals, research societies, and government health agencies worldwide.
• Cochrane RCT Classifier Integrated machine learning classifier embedded in the Covidence Platform that quickly and accurately filters out non-Randomized Controlled Trial studies during the title and abstract screening stage, reducing manual screening workload for systematic reviewers.
• AI Screening Automation AI-powered screening capability within the Covidence Platform that uses relevance-based study sorting, automated RCT tagging, and large language model interpretation of inclusion/exclusion criteria to accelerate title and abstract screening while maintaining human oversight through a responsible-AI decision matrix.
• AI Data Extraction Suggestions AI-generated suggestions within the Covidence Platform that populate data extraction fields such as sponsorship source, study design, country, sample size, interventions, outcomes, and funders with supporting quotes and confidence indicators to accelerate the extraction workflow.

Quantifiable outcome

• 35% reduction in time spent per review
• +4 more outcomes

Named customers16 records

Segments6 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration10 records

AI capability5 records

Feature9 records

Partnerships

Four partnerships are on record, tiered flagship and core.

• CochraneflagshipStrategic or Co-development Partner · 1 January 2015In 2015, Cochrane adopted Covidence as the standard production platform for Cochrane Reviews. Covidence works closely with Cochrane to support the Cochrane mission and continues the history of Cochrane evidence as the benchmark for trustworthy health evidence. This is the company's flagship partnership providing significant credibility and user base.
• Johanna Briggs InstitutecoreStrategic or Co-development PartnerCovidence partners with the Johanna Briggs Institute, an international evidence-based healthcare research organization. Collaboration supports best practice in evidence synthesis methodology.
• Campbell CollaborationcoreStrategic or Co-development PartnerCovidence partners with the Campbell Collaboration, which produces systematic reviews in social and behavioral science fields. Supports cross-disciplinary evidence synthesis.
• Guidelines International NetworkcoreStrategic or Co-development PartnerPartnership with Guidelines International Network supports the development and updating of clinical guidelines using systematic review methodology.

Scale indicators9 records

Recent moves6 records

Expansion highlights5 records

Emerging players

• Nested Knowledge: Nested Knowledge offers an integrated systematic review and evidence visualization platform with AI-assisted screening. It targets similar medical research and HTA use cases but with more emphasis on visual knowledge graphs and continuous literature monitoring.
• Semantic Scholar / Allen AI: Semantic Scholar (Allen Institute for AI) is an AI-powered academic search and discovery platform increasingly used by systematic reviewers as a literature source. While not a direct systematic review management competitor, it represents the broader AI-driven disruption to research workflow tooling that could pressure Covidence's upstream value proposition.

Broad incumbents

• Clarivate (EndNote + literature tools): Clarivate owns EndNote and offers adjacent scholarly research workflow tools including literature management and analytics. While not a direct systematic review competitor, Clarivate is a broad incumbent in the research workflow stack and could expand into evidence synthesis to bundle around its existing citation management base.
• Ex Libris (Clarivate): Ex Libris provides library management systems used by many of the same universities that license Covidence. As a broad incumbent in academic library infrastructure, it represents both a channel partner and a potential bundling threat for institutional research workflow tools.
• Elsevier (Embase, Scopus): Elsevier operates literature databases (Embase, Scopus) and offers related research workflow tools serving the same systematic reviewer audience. It is a broad incumbent with overlap in literature discovery and could move further into screening and review management as part of a vertically integrated research platform.

Direct peers

• Evidence Partners (DistillerSR): Evidence Partners' DistillerSR is the closest direct competitor to Covidence, offering cloud-based systematic review management software with AI-assisted screening used by Cochrane reviewers, regulators, and HTA agencies. Both target the same academic and health research buyer with overlapping feature sets for screening, data extraction, and risk of bias assessment.
• EPPI-Reviewer: EPPI-Reviewer is an established systematic review platform developed at UCL's EPPI-Centre and used heavily in social science and education research. It directly competes with Covidence for institutional accounts in the social sciences, with overlapping AI screening and machine-learning classifier capabilities.
• Rayyan: Rayyan is a web-based systematic review tool with AI-powered screening (Rayyan IRR, semi-automated tagging) widely used by academic researchers. It competes head-to-head with Covidence in the individual/small-team segment with a freemium pricing model that pressures Covidence's individual subscription tier.

Others

• JBI SUMARI: JBI's SUMARI is a systematic review software platform developed and distributed by the Johanna Briggs Institute, which is also a Covidence partner. It serves overlapping healthcare evidence synthesis use cases but operates more as a complementary tool within the JBI methodology framework.

Regional players

• RevMan (Cochrane): RevMan is Cochrane's free meta-analysis and review writing tool, used downstream of Covidence for synthesis. It is not a direct competitor for screening and data extraction but is the de facto companion tool in Cochrane's production workflow, making the partnership strategic rather than competitive for Cochrane-affiliated reviews.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/covidence
• YouTubeyoutube.com/channel/UCgr_cyJlrKYBjxjyMe2z9mw
• LinkedInlinkedin.com/company/covidence-org

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Covidence